Faeth Therapeutics, Inc. ($FTH)
Filing Information
| Accession Number | 0001780030-26-000006 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 2, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
13,634
Total Value
$326,127.38
P&L
+47.9% (+$156,107.20)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Jun 29, 2026 | Purchase | 831 | $23.34 | $19,395.54 | 33,885 | Indirect | See footnote | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 30, 2026 | Purchase | 1,910 | $22.95 | $43,834.50 | 35,795 | Indirect | See footnote | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 30, 2026 | Purchase | 1,638 | $23.88 | $39,115.44 | 37,433 | Indirect | See footnote | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 30, 2026 | Purchase | 4,255 | $24.98 | $106,289.90 | 41,688 | Indirect | See footnote | View Details | |
Chief Financial Officer | Common Stock | โ | Jul 1, 2026 | Purchase | 4,400 | $23.40 | $102,960.00 | 46,088 | Indirect | See footnote | View Details | |
Chief Financial Officer | Common Stock | โ | Jul 1, 2026 | Purchase | 600 | $24.22 | $14,532.00 | 46,688 | Indirect | See footnote | View Details |